Calton & Associates’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-9,608
| Closed | -$298K | – | 409 |
|
|
2021
Q4 | $298K | Sell |
9,608
-168
| -2% | -$5.21K | 0.08% | 260 |
|
|
2021
Q3 | $237K | Buy |
+9,776
| New | +$237K | 0.05% | 340 |
|
|
2021
Q2 | – | Sell |
-10,098
| Closed | -$252K | – | 429 |
|
|
2021
Q1 | $252K | Buy |
10,098
+13
| +0.1% | +$324 | 0.05% | 321 |
|
|
2020
Q4 | $275K | Sell |
10,085
-368
| -4% | -$10K | 0.05% | 285 |
|
|
2020
Q3 | $193K | Sell |
10,453
-317
| -3% | -$5.85K | 0.04% | 321 |
|
|
2020
Q2 | $220K | Sell |
10,770
-63
| -0.6% | -$1.29K | 0.05% | 281 |
|
|
2020
Q1 | $158K | Buy |
+10,833
| New | +$158K | 0.04% | 277 |
|